Original Research
Published on 24 Mar 2025
Telitacicept as an alternative to non-steroidal immunosuppressive therapies in the treatment of myasthenia gravis: a study on clinical efficacy and steroid-sparing effect
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- 2,351 views